<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-199X</journal-id>
<journal-title><![CDATA[Revista odontológica mexicana]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Odont. Mex]]></abbrev-journal-title>
<issn>1870-199X</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Facultad de Odontología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-199X2020000100020</article-id>
<article-id pub-id-type="doi">10.22201/fo.1870199xp.2020.24.1.77548</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad respiratoria exacerbada por aspirina (EREA), un padecimiento poco conocido por los odontólogos. Una guía para su estudio y su manejo]]></article-title>
<article-title xml:lang="en"><![CDATA[Aspirin exacerbated respiratory disease (AERD), a disease little known to the dentist. Study guide and management]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Prado Bernal]]></surname>
<given-names><![CDATA[Nubia Yadira]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Salgado]]></surname>
<given-names><![CDATA[Héctor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Badillo Barba]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma Metropolitana Departamento Atención a la Salud ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma Metropolitana  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>20</fpage>
<lpage>29</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-199X2020000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-199X2020000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-199X2020000100020&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La enfermedad respiratoria exacerbada por aspirina (EREA), caracterizada por este conjunto de síntomas principalmente: pólipos nasales, sinusitis crónica, asma y sensibilidad a cualquier medicamento que inhiba la ciclooxigenasa 1 (COX-1), la aspirina y otros fármacos antiinflamatorios no esteroides. La ingesta de aspirina y la mayoría de los AINES da como resultado un espectro de reacciones alérgicas manifestadas principalmente en las vías respiratorias superiores y/o inferiores, pudiéndose complicar gravemente en un laringoespasmo y/o broncoespasmo  Objetivo: Realizar una guía de estudio sencilla para alertar al odontólogo general en el manejo analgésico de los pacientes con EREA.  Conclusión: La EREA es una enfermedad crónica, poco diagnosticada, requiere una cuidadosa historia clínica e interrogatorio de historia previa de alergias tanto farmacológicas como alimenticias, con especial atención en los pacientes asmáticos, que pudieran desencadenar reacciones alérgicas ante nuestro manejo analgésico convencional secundario a un tratamiento odontológico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Aspirin-exacerbated respiratory disease (AERD) is chiefly characterized by the following symptoms: nasal polyps, chronic sinusitis, asthma, and sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the enzymecyclooxygenase-1 (COX-1). Ingestion of aspirin and most NSAIDs may result in a spectrum of allergic reactions manifested mainlyin the upper and/or lower airways. The allergic reaction can become severely complicated and produce laryngospasm and/or bronchospasm.  Objective: To create a simple study guide to alertthe general dentist in the analgesic management of patients with AERD.  Conclusion: AERD is a chronic, underdiagnosed disease that requires performing a patient&#8217;s careful medical history and interrogation of prior history of both pharmacological and food allergies, with special attention in asthmatic patients, as asthma may trigger allergic reactions to our conventional analgesic management secondary to dental treatment.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad respiratoria exacerbada por aspirina]]></kwd>
<kwd lng="es"><![CDATA[desensibilización a la aspirina]]></kwd>
<kwd lng="es"><![CDATA[sinusitis crónica]]></kwd>
<kwd lng="es"><![CDATA[asma]]></kwd>
<kwd lng="es"><![CDATA[pólipos nasales]]></kwd>
<kwd lng="es"><![CDATA[tríada de Samter]]></kwd>
<kwd lng="en"><![CDATA[Aspirin exacerbated respiratory disease]]></kwd>
<kwd lng="en"><![CDATA[aspirin desensitization]]></kwd>
<kwd lng="en"><![CDATA[chronic sinusitis]]></kwd>
<kwd lng="en"><![CDATA[asthma]]></kwd>
<kwd lng="en"><![CDATA[nasal polyps]]></kwd>
<kwd lng="en"><![CDATA[Samter&#8217;s triad]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[RU]]></given-names>
</name>
<name>
<surname><![CDATA[Stevenson]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-exacerbated respiratory disease evaluation and management]]></article-title>
<source><![CDATA[Allergy Asthma Inmmunol Res]]></source>
<year>2011</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-10</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buchheit]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Laidlaw]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update on the management of aspirin-exacerbated respiratory disease]]></article-title>
<source><![CDATA[Allergy Asthma Inmmunol Res]]></source>
<year>2016</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>298-304</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[MKE]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad respiratoria exacerbada por aspirina Revisión a partir de casos clínicos]]></article-title>
<source><![CDATA[Rev Alerg Mex]]></source>
<year>2017</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>78-91</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laidlaw]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Cahill]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current knowledge and management of hypersensitivity to aspirin and NSAIDs]]></article-title>
<source><![CDATA[J Allergy Clin Immunol Pract]]></source>
<year>2017</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>537-45</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gajardo]]></surname>
<given-names><![CDATA[OP]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[AX]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intolerancia a la aspirina en pacientes con piloposis nasal y asma bronquial]]></article-title>
<source><![CDATA[Rev Otorrinolaringol Cir Cabeza Cuello]]></source>
<year>2009</year>
<volume>69</volume>
<page-range>157-68</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castilla]]></surname>
<given-names><![CDATA[RJL]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[CME]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[BRA]]></given-names>
</name>
<name>
<surname><![CDATA[Galicia]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Castrejón]]></surname>
<given-names><![CDATA[VMI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de intolerancia a salicilatos en pacientes con poliposis nasosinusal]]></article-title>
<source><![CDATA[Revista Alergia México]]></source>
<year>2015</year>
<volume>62</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>202-10</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sommer]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Rotenberg]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Sowerby]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Janjua]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel treatment adjunct for aspirin exacerbated respiratory disease the low salicylate diet: a multicenter randomized control crossover trial]]></article-title>
<collab>Witterick IJ et al</collab>
<source><![CDATA[Int Forum Allergy Rhinol]]></source>
<year>2016</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>385-91</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rajan]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Wineinger]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Stevenson]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients a meta-analysis of the literature]]></article-title>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2015</year>
<volume>135</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>676-81</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karakaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Celebioglu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kalyoncu]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-steroidal anti- inflammatory drug hypersensitivity in adults and the factors associated with asthma]]></article-title>
<source><![CDATA[Respiratory Medicine]]></source>
<year>2013</year>
<volume>107</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>967-74</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cahill]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Boyce]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-exacerbated respiratory disease mediators and mechanisms of a clinical disease]]></article-title>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2017</year>
<volume>139</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>764-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laidlaw]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Boyce]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-exacerbated respiratory disease New prime suspects]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2016</year>
<volume>374</volume>
<page-range>484-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cowburn]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Sladek]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Soja]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Adamek]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lam]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma]]></article-title>
<collab>Austen ST et al</collab>
<source><![CDATA[J Clin Invest]]></source>
<year>1998</year>
<volume>101</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>834-46</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sakalar]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Muluk]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Kar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cingi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-exacerbated respiratory disease and current treatment modalities]]></article-title>
<source><![CDATA[Eur Arch Otorhinolaryngol]]></source>
<year>2017</year>
<volume>274</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1292-300</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laidlaw]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Kidder]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Bhattacharyya]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Xing]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes]]></article-title>
<collab>Milne GL et al</collab>
<source><![CDATA[Blood]]></source>
<year>2012</year>
<volume>119</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>3790-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mullol]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Picado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rhinosinusitis and nasal polyps in aspirin- exacerbated respiratory disease]]></article-title>
<source><![CDATA[Immunol Allergy Clin North Am]]></source>
<year>2013</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>163-76</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Stoner]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Borish]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-exacerbated respiratory disease prevalence, diagnosis, treatment, and considerations for the future]]></article-title>
<source><![CDATA[Am J Rhinol Allergy]]></source>
<year>2016</year>
<volume>30</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>407-13</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fahrenholz]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Natural history and clinical features of aspirin- exacerbated respiratory disease]]></article-title>
<source><![CDATA[Clin Rev Allergy Immunol]]></source>
<year>2003</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-24</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jares]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Borges]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Villa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ensina]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Arias-Cruz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multinational experience with hypersensitivity drug reactions in Latin America]]></article-title>
<collab>Gómez M et al</collab>
<source><![CDATA[Ann Allergy Asthma Immunol]]></source>
<year>2014</year>
<volume>113</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>282-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Raciborski]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Krzych-Falta]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Opoczynska-Swiezewska]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Szymanski]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Persons with allergy symptoms use alternative medicine more often]]></article-title>
<collab>Lipiec A et al</collab>
<source><![CDATA[Pneumonol Alergol Pol]]></source>
<year>2016</year>
<volume>84</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>251-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanns]]></surname>
<given-names><![CDATA[WB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Salicylate intolerance]]></article-title>
<source><![CDATA[Dtsch Arzteb Int]]></source>
<year>2008</year>
<volume>105</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>137-42</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Baxter]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Thies]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Kyle]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Duthie]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of salicylates in foods estimated daily intake of Scottish population]]></article-title>
<source><![CDATA[Mol Nutr Food Res]]></source>
<year>2011</year>
<volume>55</volume>
<page-range>S7-14</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calderón]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Dávila]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mantilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chérrez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Calero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge and attitudes about aspirin exacerbated respiratory disease among Ecuadorian physicians]]></article-title>
<collab>Cabrera D et al</collab>
<source><![CDATA[Rev Alerg Mex]]></source>
<year>2017</year>
<volume>64</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-23</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bernstein]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Castells]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Gawchik]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Settipane]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease a practice paper]]></article-title>
<source><![CDATA[Ann Allergy Asthma Immunol]]></source>
<year>2007</year>
<volume>98</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>172-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
